- Country: Brazil
- Summary: Acquisition of Injecting Medicines - 4Th Quarter
- BRT Ref No: 127670006
- Deadline: 20 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90175/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Acquisition of injecting medicines - 4th trimester
HS
Sodium, Concentration 50 mg, pharmaceutical form lipyl powder for injectable
LYOPHIL POWDER FOR INJECTION
COMPOSITION ASSOCIATED WITH TAZOBACTAMA, 4G + 500MG CONCENTRATION, INJECTABLE APPLICATION
Injectable solution
850
Dosage 5 mg/ml, presentation injectable solution
Dosage 10 mg/ml, indication injectable solution
: 100
DOSAGE 500 MG, PRESENTATIONLYOPHILIZED POWDER + DILUENT, INJECTABLE
Pharmaceutical Injectable solution
HYCLORHYDRATE, PURITY 0.5%, INJECTABLE SOLUTION PRESENTATION
TYPE Injectable solution - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAcquisition of Injecting Medicines - 4Th Quarter - Brazil Tender
The SAO PAULO STATE GOVERNMENT, a Government sector organization in Brazil, has announced a new tender for Acquisition of Injecting Medicines - 4Th Quarter. This tender is published on BrazilTenders under BRT Ref No: 127670006 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-20.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
